BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 21968662)

  • 1. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
    Taub AF; Garretson CB
    J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
    Van der Geer S; Krekels GA
    J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
    Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
    Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short incubation PDT versus 5-FU in treating actinic keratoses.
    Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
    J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
    Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
    Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
    Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
    Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.
    Touma D; Yaar M; Whitehead S; Konnikov N; Gilchrest BA
    Arch Dermatol; 2004 Jan; 140(1):33-40. PubMed ID: 14732657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
    Tanghetti EA; Hamann C; Tanghetti M
    J Drugs Dermatol; 2015 Nov; 14(11):1241-4. PubMed ID: 26580872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-Modulated Photodynamic Therapy for the Treatment of Actinic Keratosis on the Extremities: A One-Year Follow-up Study.
    Willey A; Anderson RR; Sakamoto FH
    Dermatol Surg; 2015 Nov; 41(11):1290-5. PubMed ID: 26445287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up.
    Sotiriou E; Apalla Z; Chovarda E; Goussi C; Trigoni A; Ioannides D
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):36-40. PubMed ID: 21366709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp.
    Pariser DM; Houlihan A; Ferdon MB; Berg JE;
    Dermatol Surg; 2016 Mar; 42(3):296-304. PubMed ID: 26863596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data.
    Szeimies RM; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Hauschild A
    Br J Dermatol; 2010 Feb; 162(2):410-4. PubMed ID: 19804593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, half-side comparative study of aminolaevulinate photodynamic therapy vs. CO(2) laser ablation in immunocompetent patients with multiple actinic keratoses.
    Scola N; Terras S; Georgas D; Othlinghaus N; Matip R; Pantelaki I; Möllenhoff K; Stücker M; Altmeyer P; Kreuter A; Gambichler T
    Br J Dermatol; 2012 Dec; 167(6):1366-73. PubMed ID: 22708798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.